We are live on
!
Find out more
PVWM
Point View Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
10.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+10.77%
3 Year Est. Return
+27.03%
5 Year Est. Return
+74.48%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$5.15M
(+2.5%)
Cap. Flow
-$2.07M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
15.14%
Holding
275
New
15
Increased
71
Reduced
139
Closed
9
Avg Time Held
10.3
quarters
Top 10 Avg Time Held
9.7
quarters
Top 20 Avg Time Held
9.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baker Hughes
BKR
|
+$1.12M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$562K |
| 3 |
Kroger
KR
|
+$399K |
| 4 |
Johnson Controls International
JCI
|
+$313K |
| 5 |
IGR
CBRE Global Real Estate Income Fund
IGR
|
+$275K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHI
Baker Hughes
BHI
|
+$1.23M |
| 2 |
MetLife
MET
|
+$397K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$312K |
| 4 |
Procter & Gamble
PG
|
+$303K |
| 5 |
Microsoft
MSFT
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 14.59% |
| 2 | Technology | 12.22% |
| 3 | Financials | 11.7% |
| 4 | Healthcare | 10.61% |
| 5 | Energy | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
General Dynamics
GD
$90.6B
| $923K | 0.44% |
4,485
+41
| +0.9% | +$8.22K |
2013 Q4
15 quarters
|
|
|
NTT
77
DELISTED
Nippon Telegraph & Telephone
NTT
| $923K | 0.44% |
20,130
-1,185
| -6% | -$54.3K |
2013 Q4
15 quarters
|
|
78
Prudential Financial
PRU
$39.2B
| $918K | 0.44% |
8,631
+80
| +0.9% | +$8.55K |
2013 Q4
15 quarters
|
|
79
Gilead Sciences
GILD
$186B
| $895K | 0.43% |
11,047
+1,582
| +17% | +$121K |
2016 Q1
6 quarters
|
|
|
AET
80
DELISTED
Aetna Inc
AET
| $886K | 0.43% |
5,569
-355
| -6% | -$55.5K |
2013 Q4
15 quarters
|
|
81
Constellation Brands
STZ
$21B
| $871K | 0.42% |
4,366
| – | – |
2013 Q4
15 quarters
|
|
82
Hewlett Packard
HPE
$93.7B
| $857K | 0.41% |
58,249
-19,141
| -25% | -$261K |
2015 Q4
7 quarters
|
|
83
Rio Tinto
RIO
$153B
| $843K | 0.4% |
17,847
-237
| -1% | -$11K |
2013 Q4
15 quarters
|
|
84
Gabelli Multimedia Trust
GGT
$194M
| $841K | 0.4% |
88,088
-8,422
| -9% | -$77.1K |
2013 Q4
15 quarters
|
|
85
Caterpillar
CAT
$373B
| $837K | 0.4% |
6,708
-1,413
| -17% | -$163K |
2015 Q3
8 quarters
|
|
|
POT
86
DELISTED
Potash Corp Of Saskatchewan
POT
| $837K | 0.4% |
43,501
+3,312
| +8% | +$59K |
2015 Q4
7 quarters
|
|
87
Sanofi
SNY
$95.8B
| $832K | 0.4% |
16,691
-1,283
| -7% | -$62.1K |
2013 Q4
15 quarters
|
|
88
Synchrony
SYF
$24.1B
| $824K | 0.4% |
26,521
+1,599
| +6% | +$47.8K |
2016 Q3
4 quarters
|
|
89
DELISTED
CA, Inc.
CA
| $809K | 0.39% |
24,213
-1,356
| -5% | -$44.8K |
2013 Q4
15 quarters
|
|
90
Trinity Industries
TRN
$2.05B
| $806K | 0.39% |
35,085
-328
| -0.9% | -$6.77K |
2015 Q2
9 quarters
|
|
|
LDF
91
DELISTED
Latin American Discovery Fund
LDF
| $802K | 0.39% |
66,333
-4,341
| -6% | -$50.1K |
2013 Q4
15 quarters
|
|
92
Goldman Sachs
GS
$260B
| $798K | 0.38% |
3,362
+227
| +7% | +$51.2K |
2015 Q3
8 quarters
|
|
93
Central and Eastern Europe Fund
CEE
$122M
| $788K | 0.38% |
31,867
-1,107
| -3% | -$25.8K |
2015 Q2
9 quarters
|
|
94
McKesson
MCK
$111B
| $770K | 0.37% |
5,010
+205
| +4% | +$32K |
2015 Q3
8 quarters
|
|
95
Unilever
UL
$135B
| $768K | 0.37% |
11,769
-217
| -2% | -$13.9K |
2015 Q1
10 quarters
|
|
96
BlackRock Credit Allocation Income Trust
BTZ
$881M
| $760K | 0.36% |
55,950
-4,509
| -7% | -$60.6K |
2015 Q3
8 quarters
|
|
97
General Motors
GM
$72.2B
| $755K | 0.36% |
18,686
-340
| -2% | -$12.4K |
2013 Q4
15 quarters
|
|
|
NMY
98
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
| $745K | 0.36% |
58,025
-2,349
| -4% | -$30.6K |
2013 Q4
15 quarters
|
|
99
CoreCivic
CXW
$3.34B
| $741K | 0.36% |
27,671
| – | – |
2016 Q3
4 quarters
|
|
100
Novartis
NVS
$273B
| $737K | 0.35% |
9,578
-553
| -5% | -$41.8K |
2013 Q4
15 quarters
|
|
Similar funds
EA
CCM
JCM
BG
MCFIG
BRC
TFM
RCA
Point View Wealth Management's Q3 2017 Portfolio in Review
As of Q3 2017, Point View Wealth Management held 275 positions worth $208M, up 2.5% from $203M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Point View Wealth Management's Q3 2017 filing shows 15 new, 71 increased, 139 reduced and 9 closed positions. Its largest new stake was Baker Hughes: 31,448 shares worth $1.15M. The largest sale was Baker Hughes, an estimated $1.23M.
By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Point View Wealth Management's largest Q3 2017 buy was Baker Hughes: 31,448 shares worth $1.15M.
- Point View Wealth Management added most to Teva Pharmaceutical Industries Limited in Q3 2017, an estimated $562K increase.
- Point View Wealth Management's biggest Q3 2017 reduction was MetLife, cutting an estimated $397K.
- Point View Wealth Management fully exited Baker Hughes in Q3 2017, selling an estimated $1.23M.
- Point View Wealth Management's ten largest holdings make up 15% of its $208M portfolio in Q3 2017.
- Point View Wealth Management opened 15 new positions and closed 9 in Q3 2017.
- Point View Wealth Management's portfolio value rose 2.5% quarter-over-quarter to $208M.
Based on Point View Wealth Management's 13F filing for Q3 2017, filed 8 Nov 2017.